US$ 29.86
bpc 157 fda status warning 2024 2025 The just announced that they're taking steps to lift restrictions on 12 peptides — including BPC-157 and TB-500 — making them accessible through compounding pharmacies again. This is a HUGE step BPC-157 FDA Approval Status: Is
Description
The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed

This protocol recommends weekly B12/MIC injections for up to 6-months (or 6 total refills)
Diabetes patients are more susceptible to mononeuropathies compared to non-diabetes individuals

Insufficient B12 can lead to serious complications like neural tube defects
